Company Overview - NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients with neurological disorders [1][2]. Proposed Offering - The company has commenced a proposed underwritten registered public offering of shares of its common stock, with all shares to be sold by the company [1][2]. - The company intends to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares sold in the offering [2]. - The offering is subject to market and other conditions, with no assurance on the completion, size, or terms of the offering [2]. Underwriter Information - Ladenburg Thalmann & Co. Inc. is acting as the sole book-running manager for the proposed offering [3]. Regulatory Compliance - The proposed offering is made pursuant to a shelf registration statement on Form S-3, which was declared effective by the U.S. Securities and Exchange Commission on August 16, 2024 [4]. - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and made available on the SEC's website [4].
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock